All Stories

  1. Parasites revive hope for cancer therapy
  2. Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis
  3. Shedding light on a mysterious link between Toxoplasma gondii and cancer: A review
  4. Prophylactic antineoplastic activity of Toxoplasma gondii RH derived antigen against ehrlich solid carcinoma with evidence of shared antigens by comparative immunoblotting
  5. Toxoplasma gondii-derived antigen modifies tumor microenvironment of Ehrlich solid carcinoma murine model and enhances immunotherapeutic activity of cyclophosphamide
  6. Evaluation of cytotoxic activity of live toxoplasma gondii tachyzoites and toxoplasma antigen on MCF-7 human breast cancer cell line
  7. Effect of alginate nanoparticles on the immunogenicity of excretory-secretory antigens against acute toxoplasmosis in murine model
  8. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni
  9. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
  10. Praziquantel lipid nanocapsules
  11. Immuno-therapeutic potential of Schistosoma mansoni and Trichinella spiralis antigens in a murine model of colon cancer
  12. Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens
  13. Repositioning of chlorambucil as a potential anti-schistosomal agent
  14. Anti-Arthritic Activity of Schistosoma mansoni and Trichinella spiralis Derived-Antigens in Adjuvant Arthritis in Rats: Role of FOXP3+ Treg Cells
  15. Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni -induced liver fibrosis in mice
  16. Miltefosine lipid nanocapsules: Intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni
  17. Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study
  18. Could miltefosine be used as a therapy for toxoplasmosis?
  19. The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice
  20. Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis
  21. Miltefosine for Old World cutaneous leishmaniasis: An experimental study on Leishmania major infected mice
  22. Initial characterization of an autoclaved Toxoplasma vaccine in mice
  23. Giardia lamblia: A new target for miltefosine
  24. Leishmania major: Activity of tamoxifen against experimental cutaneous leishmaniasis
  25. Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy
  26. Miltefosine, a promising novel agent for schistosomiasis mansoni
  27. Synthesis and biological evaluation of a novel class as antileishmanial agent
  28. Inheritance of Schistosoma mansoni infection incompatibility in Biomphalaria alexandrina snails
  29. Synthesis of Substituted Pyrimidinedione Derivatives as Potential Schistosomicidal Agents
  30. Synthesis and evaluation of some pyrimidine analogs against toxoplasmosis
  31. Topical Application of Ivermectin for Human Ectoparasites